Clinical Trials

Showing trials with last updates posted in 2021.

NCT03613168 | COMPLETED | PHASE2
4 participants

Trastuzumab in HER2-positive Biliary Tract Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2021-01-05
Start Date:
2019-06-01
Completion:
2020-11-01
Conditions
  • Cholangiocarcinoma
  • Biliary Tract Cancer
  • HER-2 Protein Overexpression
  • HER-2 Gene Amplification
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page